Stage 2 PBS Process Improvement Information Forum – Webinar recording and resources available
Page last updated: 24 September 2020
On 21 September 2020, the department hosted a webinar to provide information to industry on the Stage 2 PBS process improvements and cost recovery arrangements, which pending Government approval are expected to commence from 1 January 2021.
If you were unable to join the live webinar, please register to view the on demand webinar recording and access resource documents, including presentation slides.
If you were able to attend the webinar, please log in to access the webinar recording and resource documents.
The consultation papers are also available via the PBS Process Improvements page.
The department welcomes your feedback on the clarity of the following documents:
- Updated Procedure Guidance for the Listing of Medicines on the PBS (the full document has been provided for context. All changes are in red text).
- Updated 2020-21 Cost Recovery Implementation Statement; and
- Proposed transition arrangements.
Consultation will close on Monday, 12 October 2020. Please submit your comments and feedback to PBSImprovements@health.gov.au.
Background
The Australian Government signed a five-year strategic agreement with Medicines Australia committing to a viable medicines sector in Australia and a sustainable PBS.
The Department of Health and Medicines Australia have been working since late 2017 to deliver on commitments to streamline medicines listing processes and revise cost recovery arrangements as set out under clause 10 of the Strategic Agreement.
Improved processes and revised cost recovery arrangements support the Government’s commitment under the strategic agreement to improve the transparency, timeliness and efficiency of the Pharmaceutical Benefits Scheme (PBS) listing processes. Changes will ensure that Australians continue to receive timely and affordable access to necessary medicines.
